Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG. (Q46497571)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2005

Language	Label	Description	Also known as
English	Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG.	scientific article published in July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG. (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Radujkovic A

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Schad M

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Topaly J

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Veldwijk MR

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Laufs S

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Schultheis BS

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Jauch A

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Melo JV

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Fruehauf S

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

Zeller WJ

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

publication date

1 July 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

19

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

1198-1206

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403764

0 references

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Towards unlimited colors for fluorescence in-situ hybridization (FISH).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Karyotyping human chromosomes by combinatorial multi-fluor FISH.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Growth factors acting via tyrosine kinase receptors induce HSP90 alpha gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403764

21 January 2018

Identifiers

10.1038/SJ.LEU.2403764

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15902298

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46497571&oldid=1584523671"